$QLGN
Qualigen Therapeutics, Inc. Stock $qlgn

$qlgn Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032189 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$1.390M	$1.441M	$1.155M
YoY Change	-6.16%	24.76%	37.51%
Cost Of Revenue	$1.096M	$91.00K	$993.1K
YoY Change	-10.17%	-90.84%	7.95%
Gross Profit	$293.7K	$1.350M	$162.0K
YoY Change	12.55%	733.63%	-302.44%
Gross Profit Margin	21.13%	93.69%	14.02%
Selling, General & Admin	$2.925M	$2.858M	$2.887M
YoY Change	-10.9%	-0.99%	4.58%
% of Gross Profit	995.86%	211.69%	1782.36%
Research & Development	$1.778M	$1.688M	$2.083M
YoY Change	9.38%	-18.97%	139.46%
% of Gross Profit	605.34%	125.04%	1286.4%
Depreciation & Amortization	$52.91K	$24.00K	$28.66K
YoY Change	71.67%	-16.26%	-4.47%
% of Gross Profit	18.01%	1.78%	17.7%
Operating Expenses	$4.703M	$5.824M	$4.970M
YoY Change	-4.18%	17.19%	36.53%
Operating Profit	-$4.409M	-$4.383M	-$4.808M
YoY Change	-5.12%	-8.84%	29.24%
Interest Expense	-$42.41K	$4.630K	$6.800K
YoY Change	-827.44%	-31.91%	-100.15%
% of Operating Profit
Other Income/Expense, Net	-$111.8K	$327.1K	$1.765M
YoY Change	-126.24%	-81.47%
Pretax Income	-$8.803M	-$4.056M	-$3.036M
YoY Change	108.81%	33.57%	-62.56%
Income Tax	-$271.3K		$1.010K
% Of Pretax Income
Net Earnings	-$6.372M	-$3.825M	-$3.037M
YoY Change	51.04%	25.93%	-62.55%
Net Earnings / Revenue	-458.46%	-265.44%	-262.97%
Basic Earnings Per Share		-$0.10	-$0.10
Diluted Earnings Per Share	-$1.51	-$1.028M	-$104.6K
COMMON SHARES
Basic Shares Outstanding	42.11M shares	38.80M shares	29.03M shares
Diluted Shares Outstanding		3.944M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.034M	$6.618M	$12.32M
YoY Change	-59.89%	-46.28%	-14.86%
Cash & Equivalents	$7.040M	$6.624M	$12.32M
Short-Term Investments
Other Short-Term Assets	$12.63K	$1.692M	$1.602M
YoY Change	-99.09%	5.68%	-17.02%
Inventory	$1.586M	$1.482M	$1.178M
Prepaid Expenses
Receivables	$538.6K	$603.3K	$633.6K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.82M	$10.40M	$15.73M
YoY Change	-47.97%	-33.93%	-10.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$345.1K	$311.5K	$475.8K
YoY Change	68.98%	-34.52%	-77.13%
Goodwill	$625.6K	$4.896M
YoY Change
Intangibles	$5.846M	$5.852M
YoY Change	3314.75%
Long-Term Investments
YoY Change
Other Assets	$18.33K	$18.33K	$18.33K
YoY Change	0.0%	0.02%	-8.35%
Total Long-Term Assets	$8.263M	$12.56M	$671.7K
YoY Change	305.18%	1770.44%	-78.4%
TOTAL ASSETS
Total Short-Term Assets	$10.82M	$10.40M	$15.73M
Total Long-Term Assets	$8.263M	$12.56M	$671.7K
Total Assets	$19.08M	$22.96M	$16.40M
YoY Change	-16.43%	39.95%	-20.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$857.3K	$596.0K	$908.7K
YoY Change	-3.26%	-34.41%	121.63%
Accrued Expenses	$1.512M	$1.471M	$2.024M
YoY Change	-15.72%	-27.32%	115.35%
Deferred Revenue
YoY Change
Short-Term Debt	$950.7K	$941.3K	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$8.608M	$4.881M	$5.427M
YoY Change	85.7%	-10.06%	-76.51%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$1.351M	$1.426M	$131.5K
YoY Change	-17.4%	984.48%	-57.58%
Total Long-Term Liabilities	$1.351M	$1.426M	$131.5K
YoY Change	-17.4%	984.48%	-72.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.608M	$4.881M	$5.427M
Total Long-Term Liabilities	$1.351M	$1.426M	$131.5K
Total Liabilities	$10.32M	$7.043M	$5.558M
YoY Change	64.52%	26.71%	-76.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$103.4M	-$97.00M
YoY Change	22.01%
Common Stock	$42.11K	$42.11K
YoY Change	19.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.236M	$12.15M	$10.85M
YoY Change
Total Liabilities & Shareholders Equity	$19.08M	$22.96M	$16.40M
YoY Change	-16.43%	39.95%	-20.67%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$6.372M	-$3.825M	-$3.037M
YoY Change	51.04%	25.93%	-62.55%
Depreciation, Depletion And Amortization	$52.91K	$24.00K	$28.66K
YoY Change	71.67%	-16.26%	-4.47%
Cash From Operating Activities	-$2.238M	-$3.182M	-$3.032M
YoY Change	-23.19%	4.94%	-32.91%
INVESTING ACTIVITIES
Capital Expenditures	$244.4K	-$11.26K	-$9.670K
YoY Change	-1537.53%	16.44%	-94.63%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$244.4K	-$11.26K	-$9.670K
YoY Change	1337.47%	16.44%	-94.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$129.4K
YoY Change			-99.28%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.903M	3.310K	129.4K
YoY Change	-64.37%	-97.44%	-99.23%
NET CHANGE
Cash From Operating Activities	-2.238M	-3.182M	-3.032M
Cash From Investing Activities	-244.4K	-11.26K	-9.670K
Cash From Financing Activities	2.903M	3.310K	129.4K
Net Change In Cash	421.2K	-3.190M	-2.913M
YoY Change	-91.93%	9.52%	-124.11%
FREE CASH FLOW
Cash From Operating Activities	-$2.238M	-$3.182M	-$3.032M
Capital Expenditures	$244.4K	-$11.26K	-$9.670K
Free Cash Flow	-$2.482M	-$3.171M	-$3.023M
YoY Change	-14.3%	4.9%	-30.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001460702
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	QLGN	Research And Development Grant Liability ResearchAndDevelopmentGrantLiability		usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2021Q1	QLGN	Stock Issued Upon Netexercise Of Warrants StockIssuedUponNetexerciseOfWarrants		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	QLGN	Increase Decrease In Research And Development Grant Liability IncreaseDecreaseInResearchAndDevelopmentGrantLiability		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	QLGN	Transfers Of Inventory From Equipment Held For Lease TransfersOfInventoryFromEquipmentHeldForLease		usd
	QLGN	Fair Value Of Shares Issued For Cashless Warrant Exercises FairValueOfSharesIssuedForCashlessWarrantExercises		usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired		usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1		usd
	QLGN	Fair Value Of Warrants Repriced Due To Acquisition FairValueOfWarrantsRepricedDueToAcquisition		usd
	QLGN	Fair Value Of Qualigen Prefunded Warrant Issued In Exchange For Nanosynex Stock FairValueOfQualigenPrefundedWarrantIssuedInExchangeForNanosynexStock		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1		usd
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q3	QLGN	Dilutive Potential Shares Issuable From Stock Options And Warrants DilutivePotentialSharesIssuableFromStockOptionsAndWarrants		shares
CY2021Q3	QLGN	Dilutive Potential Shares Issuable From Stock Options And Warrants DilutivePotentialSharesIssuableFromStockOptionsAndWarrants		shares
	QLGN	Dilutive Potential Shares Issuable From Stock Options And Warrants DilutivePotentialSharesIssuableFromStockOptionsAndWarrants		shares
	QLGN	Dilutive Potential Shares Issuable From Stock Options And Warrants DilutivePotentialSharesIssuableFromStockOptionsAndWarrants		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	Qualigen Therapeutics, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-37428
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3474527
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2042 Corte Del Nogal
	dei	Entity Address City Or Town EntityAddressCityOrTown	Carlsbad
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92011
	dei	City Area Code CityAreaCode	(760)
	dei	Local Phone Number LocalPhoneNumber	918-9165
	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
	dei	Trading Symbol TradingSymbol	QLGN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42110182	shares
CY2022Q3	us-gaap	Cash Cash	6618141	usd
CY2021Q4	us-gaap	Cash Cash	17538272	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	603291	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	822351	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1481524	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1055878	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1692472	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1379896	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	10395428	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20796397	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5624	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1479618	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1645568	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	311531	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	596039	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	886224	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1471327	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1793901	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204216	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5852074	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	171190	usd
CY2022Q3	us-gaap	Goodwill Goodwill	4896223	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18334	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18334	usd
CY2022Q3	us-gaap	Assets Assets	22958832	usd
CY2021Q4	us-gaap	Assets Assets	22835705	usd
CY2022Q3	QLGN	Research And Development Grant Liability ResearchAndDevelopmentGrantLiability	905603	usd
CY2022Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	102640	usd
CY2021Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	135063	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	198373	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134091	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	941261	usd
CY2022Q3	us-gaap	Hedging Liabilities Current HedgingLiabilitiesCurrent	666000	usd
CY2021Q4	us-gaap	Hedging Liabilities Current HedgingLiabilitiesCurrent	1686200	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4881243	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4635479	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1365459	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1542564	usd
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	60521	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	92928	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	736000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	7043223	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6270971	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	225000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	225000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42110182	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42110182	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35290178	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35290178	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	42110	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	35290	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	108967248	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	101274073	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	154063	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97012929	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84744629	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12150492	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16564734	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	3765117	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15915609	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16564734	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22958832	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22835705	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1441065	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1155065	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3593628	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4172496	usd
CY2022Q3	QLGN	Cost Of Product Sales CostOfProductSales	1278029	usd
CY2021Q3	QLGN	Cost Of Product Sales CostOfProductSales	993120	usd
	QLGN	Cost Of Product Sales CostOfProductSales	3206553	usd
	QLGN	Cost Of Product Sales CostOfProductSales	3112224	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2618021	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2756323	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8177627	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8582361	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1688096	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2083315	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5059067	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10091155	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	239865	usd
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	130217	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	683291	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	402347	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5824011	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	5962975	usd
	us-gaap	Operating Expenses OperatingExpenses	17126538	usd
	us-gaap	Operating Expenses OperatingExpenses	22188087	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4382946	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4807910	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13532910	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18015591	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	321300	usd
CY2021Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1763936	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1019342	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4299000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4631	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6801	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15763	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	36863	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1139	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	702	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	795	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3596	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	327070	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1771439	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1035900	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4339459	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4055876	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3036471	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12497010	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13676132	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1011	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6173	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2146	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-4055876	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-3037482	usd
	us-gaap	Profit Loss ProfitLoss	-12503183	usd
	us-gaap	Profit Loss ProfitLoss	-13678278	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-230767	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-234883	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3825109	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3037482	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12268300	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13678278	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39444058	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29026211	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37154623	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28683972	shares
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-4055876	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-3037482	usd
	us-gaap	Profit Loss ProfitLoss	-12503183	usd
	us-gaap	Profit Loss ProfitLoss	-13678278	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	88523	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	154063	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3967353	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3037482	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12349120	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13678278	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-230767	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-234883	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3736586	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3037482	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12114237	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13678278	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16564734	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18470143	usd
CY2022Q3	QLGN	Stock Issued Upon Cash Exercise Of Warrants StockIssuedUponCashExerciseOfWarrants	3315	usd
CY2022Q1	QLGN	Stock Issued Upon Cash Exercise Of Warrants StockIssuedUponCashExerciseOfWarrants	4716	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	1267166	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-4319787	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13516829	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1844500	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1746816	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	65540	usd
CY2022Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	4000000	usd
CY2022Q2	QLGN	Fair Value Of Warrant Modification For Business Acquisition FairValueOfWarrantModificationForBusinessAcquisition	696	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1423282	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-4127520	usd
CY2022Q3	QLGN	Foreign Currency Translation Adjustment ForeignCurrencyTranslationAdjustment	88523	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-4055876	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15915609	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18294560	usd
CY2021Q1	QLGN	Stock Issued Upon Cash Exercise Of Warrants StockIssuedUponCashExerciseOfWarrants	1814673	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	101750	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1262123	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-5242719	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16230387	usd
CY2021Q2	QLGN	Stock Issued Upon Cash Exercise Of Warrants StockIssuedUponCashExerciseOfWarrants	142582	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1286926	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-5398077	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12261818	usd
CY2021Q3	QLGN	Stock Issued Upon Cash Exercise Of Warrants StockIssuedUponCashExerciseOfWarrants	129425	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1313357	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-3037482	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10667118	usd
	us-gaap	Profit Loss ProfitLoss	-12503183	usd
	us-gaap	Profit Loss ProfitLoss	-13678278	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	99661	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82404	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	165949	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	166657	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	87370	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15295	usd
	us-gaap	Inventory Write Down InventoryWriteDown	12417	usd
	us-gaap	Inventory Write Down InventoryWriteDown	20040	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	101750	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4099952	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3862406	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1019342	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4299000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-203697	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33088	usd
	QLGN	Increase Decrease In Inventory And Equipment Held For Leases IncreaseDecreaseInInventoryAndEquipmentHeldForLeases	438063	usd
	QLGN	Increase Decrease In Inventory And Equipment Held For Leases IncreaseDecreaseInInventoryAndEquipmentHeldForLeases	138885	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	313166	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1077381	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-294513	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	407933	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-539907	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1052693	usd
	QLGN	Increase Decrease In Research And Development Grant Liability IncreaseDecreaseInResearchAndDevelopmentGrantLiability	-393033	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-112823	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-187671	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-64830	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-267047	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11009814	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11817410	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74743	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	117463	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6893	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	135354	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	60611	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-124356	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7173	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	423744	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	138739	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7173	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	285005	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10942030	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11656761	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27523	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17538272	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23976570	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6623765	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12319809	usd
	us-gaap	Interest Paid Net InterestPaidNet	1233	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3501	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2200	usd
	QLGN	Transfers Of Inventory From Equipment Held For Lease TransfersOfInventoryFromEquipmentHeldForLease	1304	usd
	QLGN	Fair Value Of Shares Issued For Cashless Warrant Exercises FairValueOfSharesIssuedForCashlessWarrantExercises	722970	usd
	QLGN	Fair Value Of Warrant Liabilities On Date Of Exercise FairValueOfWarrantLiabilitiesOnDateOfExercise	858	usd
	QLGN	Fair Value Of Warrant Liabilities On Date Of Exercise FairValueOfWarrantLiabilitiesOnDateOfExercise	1841900	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	5896278	usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	2439620	usd
	QLGN	Fair Value Of Warrants Repriced Due To Acquisition FairValueOfWarrantsRepricedDueToAcquisition	696	usd
	QLGN	Fair Value Of Qualigen Prefunded Warrant Issued In Exchange For Nanosynex Stock FairValueOfQualigenPrefundedWarrantIssuedInExchangeForNanosynexStock	1746816	usd
	us-gaap	Stock Issued1 StockIssued1	1844500	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	135354	usd
CY2022Q3	us-gaap	Cash Cash	6618141	usd
CY2021Q3	us-gaap	Cash Cash	12319809	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5624	usd
CY2022Q3	QLGN	Total Cash And Restricted Cash TotalCashAndRestrictedCash	6623765	usd
CY2021Q3	QLGN	Total Cash And Restricted Cash TotalCashAndRestrictedCash	12319809	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zTPAsDhbkNz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zAlnQqd1K0ae">Accounting Estimates</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing its unaudited condensed financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. The most significant estimates relate to the estimated fair value of in-process research and development, goodwill, warrant liabilities, stock-based compensation, amortization and depreciation, inventory reserves, allowances for doubtful accounts and returns, and warranty costs. Actual results could vary from the estimates that were used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2022Q3	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2021Q3	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	763766	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1070196	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	160475	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	247845	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	603291	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	822351	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	91000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	29000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	201000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	88000	usd
CY2022Q3	QLGN	Allowances For Sales Return AllowancesForSalesReturn	56000	usd
CY2021Q3	QLGN	Allowances For Sales Return AllowancesForSalesReturn	0	usd
	QLGN	Allowances For Sales Return AllowancesForSalesReturn	109000	usd
	QLGN	Allowances For Sales Return AllowancesForSalesReturn	1000	usd
CY2022Q3	us-gaap	Product Warranty Expense ProductWarrantyExpense	91000	usd
CY2021Q3	us-gaap	Product Warranty Expense ProductWarrantyExpense	28000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	41000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	72000	usd
CY2022Q3	us-gaap	Cash Cash	6600000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97000000.0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11000000.0	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14700000	usd
CY2021Q4	QLGN	Proceeds From Issuance Or Sale Of Equity And Debt ProceedsFromIssuanceOrSaleOfEquityAndDebt	8820000	usd
	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company with a face value equal to the amount paid by the Company to NanoSynex upon satisfaction of the applicable performance milestone, bearing interest at the rate of 9% per annum on the principal balance from time to time outstanding under the particular promissory note, convertible at the option of the Company into additional shares of NanoSynex in order for the Company to maintain at least a 50.1% controlling ownership interest in NanoSynex, should NanoSynex issue additional shares. The principal of the convertible notes are due and payable upon the sooner to occur of: i) five years from the date of issuance of the particular promissory note
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	70478	shares
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	75336	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	120942	usd
CY2022Q2	QLGN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Research And Development Expense BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentExpense	5700000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	4588	usd
CY2022Q2	QLGN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses And Other Payables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherPayables	-291093	usd
CY2022Q2	QLGN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Research And Development Grant Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentGrantLiability	-1362264	usd
CY2022Q2	QLGN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Short Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt	-941898	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue	736000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	-4000000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	1439565	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4896223	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	3456658	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3593628	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4172496	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-12748015	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-14026542	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1023263	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	823315	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	228882	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	188135	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	229379	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44428	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1481524	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1055878	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1564161	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1197726	usd
CY2022Q3	QLGN	Prepaid Manufacturing Expenses PrepaidManufacturingExpenses	38056	usd
CY2021Q4	QLGN	Prepaid Manufacturing Expenses PrepaidManufacturingExpenses	67410	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	90255	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	114760	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1692472	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1379896	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3750580	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3564540	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3439049	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3360324	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	311531	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204216	usd
CY2022Q3	us-gaap	Depreciation Depreciation	24000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	19000	usd
	us-gaap	Depreciation Depreciation	72000	usd
	us-gaap	Depreciation Depreciation	51000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	4896223	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	745865	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	726749	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	152074	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	171190	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5852074	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	171190	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	18000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	15000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14000	usd
CY2022Q3	QLGN	Accrued Compensation AccruedCompensation	26500	usd
CY2021Q4	QLGN	Accrued Compensation AccruedCompensation	17500	usd
CY2022Q3	QLGN	Accrued Franchise Sales And Use Taxes AccruedFranchiseSalesAndUseTaxes	22685	usd
CY2021Q4	QLGN	Accrued Franchise Sales And Use Taxes AccruedFranchiseSalesAndUseTaxes	14090	usd
CY2022Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4356	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3620	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	225270	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	682036	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	76555	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	225308	usd
CY2022Q3	QLGN	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	210419	usd
CY2021Q4	QLGN	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	232712	usd
CY2022Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	13009	usd
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	10152	usd
CY2022Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	439324	usd
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	282910	usd
CY2022Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	137293	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	60281	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	315916	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	265292	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1471327	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1793901	usd
CY2021Q4	QLGN	Fair Value Adjustment Of Warrant FairValueAdjustmentOfWarrant	1686200	usd
	QLGN	Fair Value Of Warrant Liabilities On Date Of Exercise FairValueOfWarrantLiabilitiesOnDateOfExercise	858	usd
	QLGN	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	-1019342	usd
CY2022Q3	QLGN	Fair Value Adjustment Of Warrant FairValueAdjustmentOfWarrant	666000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3825109	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3037482	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12268300	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13678278	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39444058	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29026211	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37154623	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28683972	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	39444058	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	29026211	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37154623	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28683972	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16880489	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13737576	shares
CY2021Q4	us-gaap	Area Of Land AreaOfLand	22624	sqft
CY2021Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P61M
CY2021Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	November 1, 2022 to November 30, 2027
CY2021Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P61M
CY2021Q4	us-gaap	Payments For Rent PaymentsForRent	1950710	usd
CY2021Q4	QLGN	Tenant Improvement Allowance TenantImprovementAllowance	339360	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y2M12D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.089	pure
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	55721	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	368341	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	379392	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	390773	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	402497	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	379165	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1975889	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	412056	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1563832	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	114000	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	83000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	348000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	255000	usd
CY2022Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	96558	usd
CY2022Q1	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	150000	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	160000	usd
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16880489	shares
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16880489	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000000.0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3900000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4700000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y25D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.03	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.02	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0158	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0303	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0084	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0118	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022Q3	us-gaap	Share Price SharePrice	0.52
CY2021Q3	us-gaap	Share Price SharePrice	2.12
	us-gaap	Share Based Compensation ShareBasedCompensation	4099952	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3862406	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	600000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.32
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	300000	usd
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	2191010	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.07

Files In Submission

Name	View Source	Status
0001493152-22-032189-index-headers.html	Edgar Link	pending
0001493152-22-032189-index.html	Edgar Link	pending
0001493152-22-032189.txt	Edgar Link	pending
0001493152-22-032189-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qlgn-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
qlgn-20220930_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
qlgn-20220930_lab.xml	Edgar Link	unprocessable
qlgn-20220930_pre.xml	Edgar Link	unprocessable
qlgn-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QLGN
Qualigen Therapeutics, Inc. Stock $qlgn

2022 Q4 Form 10-Q Financial Statement

#000149315222032189 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QLGN Qualigen Therapeutics, Inc. Stock $qlgn

2022 Q4 Form 10-Q Financial Statement

#000149315222032189 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QLGN
Qualigen Therapeutics, Inc. Stock $qlgn